International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 3 , ISSUE 1 ( January-April, 2012 ) > List of Articles

RESEARCH ARTICLE

Iron-deficiency Anemia in Pregnant Women: What preventing Practitioners from using IV Iron Sucrose

Hema Divakar

Citation Information : Divakar H. Iron-deficiency Anemia in Pregnant Women: What preventing Practitioners from using IV Iron Sucrose. Int J Infertil Fetal Med 2012; 3 (1):1-7.

DOI: 10.5005/jp-journals-10016-1032

Published Online: 00-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Severe anemia in pregnancy results in relatively poor maternal and fetal outcome. Maternal effects are preterm labor, preeclampsia, sepsis and postpartum hemorrhage and increase need of blood transfusion. In India, the decision to recommend appropriate supplementation for IDA in pregnant women is left to the health care personnel and based on the individual maternal condition.

Objective

To assess the problems/limitations of health care practitioners to treat IDA with IV iron sucrose in pregnant women and to suggest ways forward for expansion of its use with confidence.

Materials and methods

The questionnaire included 18 questions altogether related to treatment, influencing factors for treatment, risk factors, attitutes and awareness about parenteral iron sucrose supplementation. All data were entered into an electronic database without personal identifiers to maintain confidentiality. The data was analyzed by using SPSS version 17.0.

Results

The survey consisted of responses from 107 health care professionals from urban and rural practitioners in India. Out of 107, 28.1% respondents said that the majority of the anemic patients were between 9.9 and 7.0 mg/dl Hb—moderate category. A total of 78 (72.90%) said that they would recheck Hb levels 4 weeks after oral ion treatment for checking the patient's response. Of the respondents, 42.52% of them said that the women were compliant and took supplementation as per prescription. All respondents agreed that there could be a mean 58% reduction of blood transfusions by using IV iron sucrose. Many respondents (74, 79.44%) expressed interest to have more information from recent research to expand the indications for use.

Conclusion

Dissemination of information related to IV iron sucrose to all practitioners and reduction in costs would help them to expand the use with confidence and avert many complications related to maternal and fetal health due to gestational anemia.

How to cite this article

Divakar H. Iron-deficiency Anemia in Pregnant Women: What preventing Practitioners from using IV Iron Sucrose. Int J Infertility Fetal Med 2012;3(1): 1-7.


PDF Share
  1. Prevalence of anaemia in pregnancy. Indian J Nutr Diet 1994;31:26-32.
  2. Failed response to treat anaemia in pregnancy: Reasons and evaluation. J Obstet Gynecol 1999;suppl:S23-27.
  3. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000;72:257-64.
  4. Iron therapy in irondeficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol Mar 2002;186(3):518-22.
  5. Effects of maternal anemia on fetal parameters. J Ayub Med Coll Abbottabad 2001;13:38-41.
  6. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 2001;107:1381-86.
  7. Irondeficiency anemia in infancy: Long-lasting effects on auditory and visual system functioning. Pediatr Res 2003;53:217-23.
  8. Iron supplementation for unexplained fatigue in non-anaemic women: Double blind randomised placebo controlled trial. BMJ 2003;326:1124.
  9. Effectiveness and strategies of iron supplementation during pregnancy. American Journal of Clinical Nutrition 2000;71:1288-94.
  10. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: An overview of randomized controlled trials. Journal of Nutrition 2003;5:1606-25.
  11. Why is iron important and what to do about it?: A new perspective. Report of the 2001 INACG Symposium; Feb 2001, 15-16; Hanoi, Vietnam 2002;1-50.
  12. Evaluation of national nutritional anemia prophylaxis programme. Indian J Pediatr 1990;57:183-90.
  13. Recommendations to prevent and control iron deficiency in the United States. Morbidity and mortality weekly report 1998;47(RR-3):1-29.
  14. Intravenous versus oral iron for treatment of anemia in pregnancy: A randomized trial. Obstet Gynecol 2005;106: 1335-40.
  15. Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. J Med Assoc Thai 2005;88:108-09.
  16. Comment eviter les transfusions dans le post-partum interetd unesupplementation martiale par voie intraveineuse. J Gynecol Obstet Biol Reprod 1999;28:77-78.
  17. Intravenous iron sucrose complex in the treatment of iron-deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;69: 121-24.
  18. Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia 2009;13(1):38-40.
  19. Intravenous iron sucrose complex vs oral ferrous sulfate for postpartum irondeficiency anemia. International Journal of Gynecology and Obstetrics 2005;90:238-39.
  20. Acute injury with intravenous iron and concerns regarding long-term safety. Clin J Am Soc Nephrol 2006, 1:S19-23.
  21. Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999;33:464-70.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.